Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Maart 2019

622 Posts
Pagina: 1 2 3 4 5 6 ... 32 »» | Laatste | Omlaag ↓
  1. C200 1 maart 2019 07:37
    Kiadis Pharma to present at upcoming investor conferences in

    March 2019

     

     

    Amsterdam, The Netherlands, March 1, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it is scheduled to present at the following investor conferences in March 2019.

     

    Cowen Healthcare Conference

    March 11-13, 2019, Marriott Copley Place, Boston, MA, USA

    Kiadis will be presenting on March 12th at 10:00 EST.

     

    BioCapital Europe

    March 14, 2019, Sofitel Legend Amsterdam The Grand, Amsterdam, Netherlands

    Kiadis will be presenting at 17:00 CET.

     

    Oppenheimer 29th Annual Healthcare Conference

    March 19-20, 2019, The Westin New York Grand Central, New York, NY, USA

    Kiadis will be presenting on March 19, 2019 at 14:45 EST.

     

    KBC Securities Healthcare Conference

    March 27, 2019, Convene Grand Central, New York, NY, USA

    Kiadis will be participating and hosting meetings with investors; there are no company presentations at this conference.

     

    Kiadis Contacts:

     

    Kiadis Pharma:

    Amy Sullivan, SVP, Corporate Affairs

    Tel. +1 508 479 3480

    a.sullivan@kiadis.com

    Optimum Strategic Communications:

    Mary Clark, Supriya Mathur, Hollie Vile

    Tel: +44 203 950 9144

    David Brilleslijper (Amsterdam)

    Tel: +31 610 942 514

    kiadis@optimumcomms.com

  2. forum rang 5 Endless 1 maart 2019 08:18
    quote:

    C200 schreef op 1 maart 2019 07:37:

    Kiadis Pharma to present at upcoming investor conferences in

    March 2019

     

     

    Amsterdam, The Netherlands, March 1, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it is scheduled to present at the following investor conferences in March 2019.

     

    Cowen Healthcare Conference

    March 11-13, 2019, Marriott Copley Place, Boston, MA, USA

    Kiadis will be presenting on March 12th at 10:00 EST.

     

    BioCapital Europe

    March 14, 2019, Sofitel Legend Amsterdam The Grand, Amsterdam, Netherlands

    Kiadis will be presenting at 17:00 CET.

     

    Oppenheimer 29th Annual Healthcare Conference

    March 19-20, 2019, The Westin New York Grand Central, New York, NY, USA

    Kiadis will be presenting on March 19, 2019 at 14:45 EST.

     

    KBC Securities Healthcare Conference

    March 27, 2019, Convene Grand Central, New York, NY, USA

    Kiadis will be participating and hosting meetings with investors; there are no company presentations at this conference.

     

    Kiadis Contacts:

     

    Kiadis Pharma:

    Amy Sullivan, SVP, Corporate Affairs

    Tel. +1 508 479 3480

    a.sullivan@kiadis.com

    Optimum Strategic Communications:

    Mary Clark, Supriya Mathur, Hollie Vile

    Tel: +44 203 950 9144

    David Brilleslijper (Amsterdam)

    Tel: +31 610 942 514

    kiadis@optimumcomms.com

    Lijkt me toch dat ze echt op positief advies inspelen. Weliswaar communiceert Kiadis niet goed over de voortgang v an beantwoorden van de vragen maar in hun acties geven ze wel duidelijk weer dat het goed zit.
  3. [verwijderd] 1 maart 2019 14:59
    Wellicht zal dit ooit wel gepubliceerd zijn hier op het forum. Toch nog eventjes erbij zetten.

    CHMP Agenda update 31 januari 2019

    Kiadis Pharma Netherlands B.V.; adjunctive treatment in haematopoietic stem cell transplantation (HSCT) for a malignant disease

    Scope: Request by the applicant for an extension to the clock stop to respond to the List of Outstanding Issues adopted on 20.09.2018

    Action: For adoption

    List of Outstanding Issues adopted on 20.09.2018, 25.05.2018. List of Questions adopted on 08.09.2017.

    www.ema.europa.eu/en/documents/agenda...
622 Posts
Pagina: 1 2 3 4 5 6 ... 32 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 860,01 -0,62%
EUR/USD 1,0650 +0,06%
FTSE 100 7.895,85 +0,24%
Germany40^ 17.709,60 -0,72%
Gold spot 2.393,04 +0,57%
NY-Nasdaq Composite 15.601,50 -0,52%

Stijgers

Econoc...
+5,50%
WDP
+3,12%
Retail...
+2,02%
Proximus
+1,66%
AB InBev
+1,48%

Dalers

Recticel
-2,35%
SYENSQO
-1,85%
bpost
-1,80%
Kinepolis
-1,47%
arGEN-X
-1,37%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links